U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C38H50O6
Molecular Weight 602.8
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GUTTIFERONE E

SMILES

CC(=C)[C@H](CC=C(C)C)C[C@]12C[C@H](CC=C(C)C)C(C)(C)[C@](CC=C(C)C)(C(=O)C(C(=O)C3=CC(O)=C(O)C=C3)=C1O)C2=O

InChI

InChIKey=QDKLRKZQSOQWJQ-AKAMJVKKSA-N
InChI=1S/C38H50O6/c1-22(2)11-13-27(25(7)8)20-37-21-28(15-12-23(3)4)36(9,10)38(35(37)44,18-17-24(5)6)34(43)31(33(37)42)32(41)26-14-16-29(39)30(40)19-26/h11-12,14,16-17,19,27-28,39-40,42H,7,13,15,18,20-21H2,1-6,8-10H3/t27-,28+,37+,38-/m1/s1

HIDE SMILES / InChI

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/28688721 | https://www.ncbi.nlm.nih.gov/pubmed/20373302

Guttiferone E (GE) is a prenylated benzophenone derivative and a diastereoisomer of garcinol and a double bond isomer of xanthochymol, firstly isolated from Garcinia species plants. The Garcinia species plants, which are used in folk medicine across Southeast Asian countries, contain a rich source of secondary metabolites, including xanthones, flavonoids, benzophenones, triterpenes and, particularly, the polyprenylated benzophenones. Due to the structural side chains in the isomeric forms, in most cases, the isomers guttiferone E and xanthochymol have been considered as an inseparable mixture. By this reason, there is no information about biological activities of Guttiferone E as a single compound.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Cytotoxicity and modes of action of four naturally occuring benzophenones: 2,2',5,6'-tetrahydroxybenzophenone, guttiferone E, isogarcinol and isoxanthochymol.
2013-04-15
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Leukemia cells (CCRF–CEM and HL-60), colon cancer cells (HCT116) and human glioblastoma multiforme U87MG cells were used for activity evaluation. Adherent cells were detached by treatment with 0.25% trypsin/EDTA (Invitrogen) and an aliquot of 1 x 10^4 cells was placed in each well of a 96-well cell culture plate (Thermo Scientific, Germany) in a total volume of 200 mkl. Cells were allowed to attach overnight and then were treated with different concentrations of compounds. For suspension cells, aliquots of 2 x 10^4 cells per well were seeded in 96-well-plates in a total volume of 100 mkl. The studied sample was immediately added in varying concentrations in an additional 100 mkl of culture medium to obtain a total volume of 200 mkl/well. After 24 h or 48 h, 20 mkl resazurin (Sigma–Aldrich, Germany) 0.01% w/v in ddH2O was added to each well and the plates were incubated at 37 ◦C for 4 h. Fluorescence was measured on an Infinite M2000 ProTM plate reader (Tecan, Germany) using an excitation wavelength of 544 nm and an emission wavelength of 590 nm.
Name Type Language
BICYCLO(3.3.1)NON-3-ENE-2,9-DIONE, 3-(3,4-DIHYDROXYBENZOYL)-4-HYDROXY-8,8-DIMETHYL-1,7-BIS(3-METHYL-2-BUTENYL)-5-((2R)-5-METHYL-2-(1-METHYLETHENYL)-4-HEXENYL)-, (1S,5S,7S)-
Preferred Name English
GUTTIFERONE E
Common Name English
Code System Code Type Description
FDA UNII
74F950KV9S
Created by admin on Mon Mar 31 22:05:46 GMT 2025 , Edited by admin on Mon Mar 31 22:05:46 GMT 2025
PRIMARY
CAS
147782-04-5
Created by admin on Mon Mar 31 22:05:46 GMT 2025 , Edited by admin on Mon Mar 31 22:05:46 GMT 2025
PRIMARY
PUBCHEM
76967922
Created by admin on Mon Mar 31 22:05:46 GMT 2025 , Edited by admin on Mon Mar 31 22:05:46 GMT 2025
PRIMARY